HealthQuill Atopic Dermatitis
The US regulator has extended a review of an application by Organon & Co.’s atopic dermatitis (eczema) drug by three months with a new target date set for March next year.
Health

New research links food allergies to atopic dermatitis in children

HQ Team December 19, 2024: Recent studies have revealed a significant relationship between food allergies and atopic dermatitis (AD) in pediatric patients, indicating.

Read More
Sixty percent of the patients treated with Pfizer’s Lorbrena drug, for a rare form of advanced lung cancer, were alive without disease progression after five years, according to company data.
Health Uncategorized

Review finds links between allergic diseases and mental health conditions

HQ Team November 15, 2024:Allergies are a source of great social and physical impairment for people suffering from them. Treatments are long-drawn, expensive.

Read More
The US regulator has extended a review of an application by Organon & Co.’s atopic dermatitis (eczema) drug by three months with a new target date set for March next year.
Drugs Health Pharma

USFDA postpones Organon’s eczema drug review by three months

The US regulator has extended a review of an application by Organon & Co.’s atopic dermatitis (eczema) drug by three months with a.

Read More
Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to a statement.
Drugs Health Pharma

Johnson & Johnson to buy Proteologix Inc., for $850 million in cash

HQ Team May 17, 2024: Johnson & Johnson will acquire Proteologix, Inc., a privately-held biotechnology company, for $850 million in cash, according to.

Read More